Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
Millenium Clinical Research
mi
from
Miami, FL
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Millenium Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
Logan Ophthalmic Research, LLC
mi
from
Tamarac, FL
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
Logan Ophthalmic Research, LLC
mi
from
Tamarac, FL
Click here to add this to my saved trials
Study to Evaluate QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
An Open-label, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
Study to Evaluate QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
An Open-label, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study to Evaluate QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
An Open-label, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Status: Enrolling
Updated:  12/31/1969
Scheie Eye Institute, University of Pennsylvania
mi
from
Philadelphia, PA
Study to Evaluate QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
An Open-label, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Status: Enrolling
Updated: 12/31/1969
Scheie Eye Institute, University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
An Open-label, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Status: Enrolling
Updated:  12/31/1969
Ghent University Hospital and Ghent University
mi
from
Ghent,
Study to Evaluate QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
An Open-label, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Status: Enrolling
Updated: 12/31/1969
Ghent University Hospital and Ghent University
mi
from
Ghent,
Click here to add this to my saved trials
Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma
A Randomized, Double-masked, Placebo-controlled Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Daily and Multiple Daily Ascending Doses of SHP639 Topical Ophthalmic Solution in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma (POAG)
Status: Enrolling
Updated:  12/31/1969
Central Contact
mi
from
Lexington, MA
Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma
A Randomized, Double-masked, Placebo-controlled Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Daily and Multiple Daily Ascending Doses of SHP639 Topical Ophthalmic Solution in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma (POAG)
Status: Enrolling
Updated: 12/31/1969
Central Contact
mi
from
Lexington, MA
Click here to add this to my saved trials
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
An Expanded Access Imaging of Neuroendocrine Tumors Using 68Ga-DOTA-TOC
Status: Enrolling
Updated:  12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
An Expanded Access Imaging of Neuroendocrine Tumors Using 68Ga-DOTA-TOC
Status: Enrolling
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
The Influence of Atropine on Choroidal Thickness
The Influence of Atropine on Choroidal Thickness
Status: Enrolling
Updated:  12/31/1969
State University of New York College of Optometry
mi
from
New York, NY
The Influence of Atropine on Choroidal Thickness
The Influence of Atropine on Choroidal Thickness
Status: Enrolling
Updated: 12/31/1969
State University of New York College of Optometry
mi
from
New York, NY
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of Arizona
mi
from
Phoenix, AZ
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  12/31/1969
University of Colorado Health Eye Center
mi
from
Aurora, CO
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 12/31/1969
University of Colorado Health Eye Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  12/31/1969
Bethesda Neurology, LLC
mi
from
Bethesda, MD
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 12/31/1969
Bethesda Neurology, LLC
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  12/31/1969
AKH - Medizinische Universitaet Wien
mi
from
Wien,
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 12/31/1969
AKH - Medizinische Universitaet Wien
mi
from
Wien,
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  12/31/1969
Palo Alto Medical Foundation
mi
from
Palo Alto, CA
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 12/31/1969
Palo Alto Medical Foundation
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  12/31/1969
Stanford Byers Eye Institute
mi
from
Stanford, CA
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 12/31/1969
Stanford Byers Eye Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  12/31/1969
Washington University
mi
from
Saint Louis, MO
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  12/31/1969
New York Eye & Ear Infirmary
mi
from
New York, NY
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 12/31/1969
New York Eye & Ear Infirmary
mi
from
New York, NY
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated:  12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Status: Enrolling
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
A Single-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of TOP1630 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated:  12/31/1969
Andover Eye Associates
mi
from
Andover, MA
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
A Single-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of TOP1630 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Syndrome
Status: Enrolling
Updated: 12/31/1969
Andover Eye Associates
mi
from
Andover, MA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Midwest Eye Retina Practicing at Midwest Eye Institute
mi
from
Indianapolis, IN
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Midwest Eye Retina Practicing at Midwest Eye Institute
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of Arizona
mi
from
Phoenix, AZ
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Northern California Retina Vitreous Associates Medical Group, Inc.
mi
from
Mountain View, CA
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Northern California Retina Vitreous Associates Medical Group, Inc.
mi
from
Mountain View, CA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Marietta Eye Clinic
mi
from
Marietta, GA
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Marietta Eye Clinic
mi
from
Marietta, GA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Texas Retina Associates
mi
from
Dallas, TX
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
mi
from
Houston, TX
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated:  12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis
Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients With Non-Infectious Uveitis
Status: Enrolling
Updated: 12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
Optical Head-Mounted Display Technology for Low Vision Rehabilitation
Optical Head-Mounted Display Technology for Low Vision Rehabilitation
Status: Enrolling
Updated:  12/31/1969
Kellogg Eye Center
mi
from
Ann Arbor, MI
Optical Head-Mounted Display Technology for Low Vision Rehabilitation
Optical Head-Mounted Display Technology for Low Vision Rehabilitation
Status: Enrolling
Updated: 12/31/1969
Kellogg Eye Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients
Long Term Follow Up to a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-hRPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Status: Enrolling
Updated:  12/31/1969
Jules Stein Eye Institute, UCLA School of Medicine
mi
from
Los Angeles, CA
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients
Long Term Follow Up to a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-hRPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Status: Enrolling
Updated: 12/31/1969
Jules Stein Eye Institute, UCLA School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients
Long Term Follow Up to a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-hRPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Status: Enrolling
Updated:  12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients
Long Term Follow Up to a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-hRPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Status: Enrolling
Updated: 12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients
Long Term Follow Up to a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-hRPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Status: Enrolling
Updated:  12/31/1969
Wills Eye Institute-Mid Atlantic Retina
mi
from
Philadelphia, PA
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients
Long Term Follow Up to a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-hRPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Status: Enrolling
Updated: 12/31/1969
Wills Eye Institute-Mid Atlantic Retina
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
Long Term Follow up to A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-RPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  12/31/1969
Jules Stein Eye Institute, UCLA School of Medicine
mi
from
Los Angeles, CA
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
Long Term Follow up to A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-RPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 12/31/1969
Jules Stein Eye Institute, UCLA School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
Long Term Follow up to A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-RPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
Long Term Follow up to A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-RPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
Long Term Follow up to A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-RPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  12/31/1969
Mass Eye and Ear
mi
from
Boston, MA
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
Long Term Follow up to A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-RPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 12/31/1969
Mass Eye and Ear
mi
from
Boston, MA
Click here to add this to my saved trials
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
Long Term Follow up to A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-RPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  12/31/1969
Wills Eye Institute-Mid Atlantic Retina
mi
from
Philadelphia, PA
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
Long Term Follow up to A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (MA09-RPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 12/31/1969
Wills Eye Institute-Mid Atlantic Retina
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
Vitreo-Retinal Associates
mi
from
Gainesville, FL
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Vitreo-Retinal Associates
mi
from
Gainesville, FL
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
Emory Eye Center
mi
from
Atlanta, GA
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Emory Eye Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
Wilmer Eye Institute at Johns Hopkins
mi
from
Baltimore, MD
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Wilmer Eye Institute at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
National Eye Institute/National Institutes of Health
mi
from
Bethesda, MD
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
National Eye Institute/National Institutes of Health
mi
from
Bethesda, MD
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
Massachusetts Eye and Ear
mi
from
Boston, MA
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Massachusetts Eye and Ear
mi
from
Boston, MA
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
Kellogg Eye Center at University of Michigan
mi
from
Ann Arbor, MI
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Kellogg Eye Center at University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
Rutgers University
mi
from
New Brunswick, NJ
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Rutgers University
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
Columbia University
mi
from
New York, NY
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
Duke University Eye Center
mi
from
Durham, NC
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Duke University Eye Center
mi
from
Durham, NC
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
OSHU Casey Eye Institute
mi
from
Portland, OR
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
OSHU Casey Eye Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Foundation of the Southwest
mi
from
Dallas, TX
Rate of Progression in USH2A Related Retinal Degeneration
Rate of Progression in USH2A Related Retinal Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Foundation of the Southwest
mi
from
Dallas, TX
Click here to add this to my saved trials